{
    "code": 0,
    "data": [
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call for Q3 FY26 financial results held on January 28 2026 is enclosed.",
            "news_id": "2411c9e3-1847-409b-8964-0ef6e71ce2ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13e54dbb-1fc1-4a61-bf8e-c25cc36eb18c.pdf",
            "news_date": "2026-02-03 14:48:42",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation discussing the Q3FY26 financial results is herewith enclosed.",
            "news_id": "b4ae02b0-849d-41eb-a76d-678c0cbed2a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2d8e948-faf3-460a-a9b6-50733ab37377.pdf",
            "news_date": "2026-01-28 15:08:34",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For Third Quarter And Nine Months Ended December 31 2025",
            "news_body": "Unaudited Financial Results standalone and consolidated for the quarter ended December 31 2025 is herewith enclosed",
            "news_id": "7035bea7-3da3-4988-a2c1-ac4cb307aa5b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c4b8fed-026d-45fa-bc6f-3fda8389a8c8.pdf",
            "news_date": "2026-01-28 14:53:02",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call transcript for the conference call held on October 17 2025 post announcement of the financial results for the quarter and half year ended September 30 2025  is herewith enclosed.",
            "news_id": "75bb15b5-97ce-49f9-a2d3-e7ff8c610ae8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e95b7ad8-fa66-43b3-93ac-373f01df4050.pdf",
            "news_date": "2025-10-24 11:37:23",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation discussing the Q2FY 26 unaudited financial results is herewith enclosed",
            "news_id": "e060bd4b-4451-4d85-bfbe-e37f133e8790",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30ad017a-17e4-461d-8db5-428fecd374ae.pdf",
            "news_date": "2025-10-17 12:22:59",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended September 30 2025",
            "news_body": "Unaudited financial results for the quarter and half year ended September 30 2025 is enclosed.",
            "news_id": "1d29b731-6f2b-43f6-8e24-d7308350d279",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a715fc78-af94-4e8a-a5fa-75a47b8e4c02.pdf",
            "news_date": "2025-10-17 12:01:21",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call for Q1 FY26 financial results held on July 30 2025 is attached",
            "news_id": "de578344-0cbd-45ba-8963-dc3232961f6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69baf7ec-c42e-4d8f-9254-19012d7a6fc5.pdf",
            "news_date": "2025-08-05 14:27:21",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation discussing the Q1 FY26 financial results is enclosed.",
            "news_id": "289a357b-5ff7-4992-a18b-e1da75f46d9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a14c5c5-0bc4-4c39-8ee0-7d53d8b37fee.pdf",
            "news_date": "2025-07-30 14:15:25",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For First Quarter Ended June 30 2025",
            "news_body": "The Board of Directors at its meeting held on July 30 2025 inter alia approved the Unaudited Standalone and Consolidated Financial results of the Company for the quarter ended on June 30 2025 as attached herewith.",
            "news_id": "e4896144-af76-470d-8b95-9db2cf0dff24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c38c10d3-b664-4433-b369-245b57e891ed.pdf",
            "news_date": "2025-07-30 13:39:45",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call held on May 2 2025 is enclosed.",
            "news_id": "426815f1-9d47-4952-91e3-304e7c43590f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c02afa8c-fcc9-43bf-be61-ba12109d1170.pdf",
            "news_date": "2025-05-08 15:51:56",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation discussing the Q4 FY25 financial results is enclosed herewith.",
            "news_id": "05806431-59f6-48f3-b0b3-71ae89b4f883",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3e0f293-0d8d-428f-abbe-9350103a7159.pdf",
            "news_date": "2025-05-02 13:33:54",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For Fourth Quarter And Year Ended March 31 2025",
            "news_body": "Audited standalone and consolidated financial results for the quarter and year ending March 31 2025 are enclosed.",
            "news_id": "f80c2e28-e89a-4a29-a413-d43b19f1d383",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d810af1c-c8a2-4622-ac96-fec906e53df1.pdf",
            "news_date": "2025-05-02 13:10:24",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call for Q3 FY25 Financial Results held on January 29 2025 is enclosed.",
            "news_id": "7b98e6c2-26ad-43b1-a3cb-3072962ab70c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92197edb-3a1b-469f-99e6-de951dc280ba.pdf",
            "news_date": "2025-02-01 12:55:21",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quarter ended December 31 2024 is herewith enclosed.",
            "news_id": "9c4e25c5-78fd-4ff5-a952-12271a6347ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89ce6e0b-0a50-4cdc-9f62-969c0d3c4c54.pdf",
            "news_date": "2025-01-28 18:36:05",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For Third Quarter And Nine Months Ended December 31 2024",
            "news_body": "Unaudited standalone & consolidated financial results for the quarter ended December 31 2024 is herewith enclosed.",
            "news_id": "cc35d07b-6531-4580-9c9e-676d868f7699",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b557a21b-8a63-4b0f-b194-167f2147b7cc.pdf",
            "news_date": "2025-01-28 17:57:31",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed please find transcript of Earnings Calls  held on October 29, 2024.",
            "news_id": "eb586f3a-3e32-4282-bda3-c3b9e7d30dcd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34f75710-e652-47a8-9be6-bb16584c1108.pdf",
            "news_date": "2024-11-05 14:43:36",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and half year ended September 30, 2024 is attached herewith.",
            "news_id": "5b57b83d-a8ed-46a5-ba5c-1312c5e3cc14",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba58ca59-c75e-4b59-828a-206727a5caa1.pdf",
            "news_date": "2024-10-29 12:45:16",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended September 30, 2024",
            "news_body": "Unaudited standalone and consolidated results for the quarter and half year ended September 30, 2024 is herewith attached.",
            "news_id": "6dedb59c-ad12-4189-90c1-7ee0ee9a40ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81c04d13-9024-4c83-838a-6809cadf99ef.pdf",
            "news_date": "2024-10-29 12:10:05",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call for Q1 FY25 financial results held on August 12, 2024 is attached.",
            "news_id": "3bad10ba-ae23-429d-a5fd-33091dbc5929",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e57f033-2345-4767-8305-87ff3de2fd88.pdf",
            "news_date": "2024-08-16 16:34:56",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on financial results for the first quarter ended on June 30, 2024 and other business matters is enclosed herewith.",
            "news_id": "79b35edb-b273-4260-ab1d-c2417e456760",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e221215-7ed8-461c-813e-7fbc90551879.pdf",
            "news_date": "2024-08-12 16:03:49",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For First Quarter Ended June 30, 2024",
            "news_body": "Unaudited consolidated and standalone financial results for the quarter ended as on June 30, 2024 is enclosed.",
            "news_id": "c588fadb-4994-4138-bd17-002a265e0693",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aeadae66-380a-4802-b207-b4e29094fbc0.pdf",
            "news_date": "2024-08-12 15:47:52",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call for Q4 FY24 financial results on May 13, 2024 is enclosed",
            "news_id": "a46b84c4-244c-409e-8a45-8ec3967bf9d2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bc8d8d2-5e01-400a-9e7d-908510f66e89.pdf",
            "news_date": "2024-05-17 11:13:15",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Corporate Presentation of the Company is herewith enclosed.",
            "news_id": "3dd06c16-8cb5-4f5c-b1a5-d7f73513bd2e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=747620c2-48be-43f8-8669-8b57bff19c17.pdf",
            "news_date": "2024-05-16 09:13:33",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on fourth quarter and year ended financial results as on March 31, 2024 is attached",
            "news_id": "84b4bc61-303a-49fd-a9f7-605156b85a55",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63be8a97-3408-4b57-9c67-20cba6a62be2.pdf",
            "news_date": "2024-05-11 13:57:37",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Statement & Results For Fourth Quarter And Year Ended March 31, 2024",
            "news_body": "Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2024 is attached.",
            "news_id": "7ea5edb5-dc13-4c95-8207-7e970c413c07",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e75fff1a-d2b3-45d4-87b5-7c84b692dfd9.pdf",
            "news_date": "2024-05-10 20:51:26",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We hereby enclose the transcript of the Earnings Conference Call held on February 12, 2024.",
            "news_id": "b2d37d08-b66e-42ef-a3fc-09c339625658",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f432a92-3af2-4119-8e73-898880099e45.pdf",
            "news_date": "2024-02-16 14:29:03",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for Q3 FY24 is herewith attached.",
            "news_id": "ffe022a8-85a4-4bbe-ae97-097bed2c94f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fada1183-d7e7-4bdc-9abf-2f5802e4b5fe.pdf",
            "news_date": "2024-02-12 15:13:37",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Third Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Unaudited Standalone and consolidated Financial Results for the third quarter and nine months ended December 31, 2023 as approved by Board is herewith attached.",
            "news_id": "a1569b59-875f-4de3-8e6f-1f2edcb6fad9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71ceb0a7-29a8-4589-98dc-ab573547ebdc.pdf",
            "news_date": "2024-02-12 14:33:21",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript of the earnings conference call held on November 9, 2023 as per attachment.",
            "news_id": "85e68953-9531-47c5-9523-8dd671a70e2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=570ee6f4-b579-4794-aa50-b6f0d8ad13e6.pdf",
            "news_date": "2023-11-16 15:53:29",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Earnings Call Recording Q2FY24",
            "news_body": "Audio Recording of Earnings Call on the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2023",
            "news_id": "de5972f6-271d-4e35-af91-f3586814c032",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4e972ea-7f73-455e-8cc8-8efbb5e60c3c.pdf",
            "news_date": "2023-11-09 15:08:31",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results and other matters for the quarter and half year ended September 30, 2023 as attached.",
            "news_id": "1af4d8ac-e55e-45a4-b140-ac832f2c3fe1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09a2cb85-0720-4973-9d6a-d00fa22566cb.pdf",
            "news_date": "2023-11-09 11:21:48",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended September 30, 2023",
            "news_body": "Board approved the unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2023 as per details attached.",
            "news_id": "a975d12c-0959-4eae-9209-0eb0aeabb519",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1b80a28-4507-4647-87c7-a3e37b8983a7.pdf",
            "news_date": "2023-11-08 21:28:01",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call for Q1 FY24 financial results held on August 11, 2023 is attached",
            "news_id": "fd3608d1-9614-4de2-a580-ab8e5dddbaf6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a482e17-b6e8-4452-b783-0fffed4326bc.pdf",
            "news_date": "2023-08-21 13:48:53",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on the first quarter ended financial results as on June 30, 2023 is attached.",
            "news_id": "d251d98e-efc9-4909-b495-6820d8744655",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce93d03e-1487-46bd-b7f0-c72b40643311.pdf",
            "news_date": "2023-08-11 14:59:53",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Unaudited standalone and consolidated financial results for the quarter ended June 30, 2023 as attached.",
            "news_id": "7c89639b-5cff-42ed-a85d-a16b2ef6ccd2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b3754ec-5bff-4d04-93d8-8dba4a284772.pdf",
            "news_date": "2023-08-11 12:19:06",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We hereby enclose the transcript of the Earnings conference call held on May 15, 2023 post announcement of financial results for the fourth quarter & year ended March 31, 2023",
            "news_id": "67345601-27ad-4244-912f-113989d04a2c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00238623-8d4b-4be6-b28e-e582c787db59.pdf",
            "news_date": "2023-05-19 19:41:44",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Investor Presentation on fourth quarter & year ended financial results as on March 31, 2023 and other business matters.",
            "news_id": "48f43e15-56a1-4fe0-a7d9-08a28ee0ce66",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6bdb2e5-60eb-433f-a7bc-0483be11c40f.pdf",
            "news_date": "2023-05-14 11:29:20",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Filing Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31, 2023 Due To Clerical Error In Standalone Cash Flow Statement.",
            "news_body": "Revised Filing of Audited Financial Results (Standalone And Consolidated) including Statement of Assets and Liabilities, Cash Flow Statement, Auditors Report on the Standalone and Consolidated Financial Results, Declaration of Unmodified Opinion,  for the Quarter and Year Ended March 31, 2023, due to clerical error in Standalone Cash Flow Statement is being submitted.",
            "news_id": "15cda725-56f7-4fe5-a128-7672f996932d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3acf3513-8a29-4934-b491-4ef17f584002.pdf",
            "news_date": "2023-05-13 20:25:20",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For Fourth Quarter And Year Ended March 31, 2023",
            "news_body": "We would like to inform that the Board of Directors at its meeting held on May 13, 2023 inter alia, considered and approved the Audited Standalone and consolidated Financial  Results for the fourth quarter and year ended March 31, 2023 as recommended by the Audit Committee.",
            "news_id": "c8ef3fc4-4cba-45e7-bf59-23b9173bd6a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=098c5c79-f91b-4f7c-9372-221f125b9359.pdf",
            "news_date": "2023-05-13 15:38:30",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed is  the transcript of the Earnings conference call held on February 04, 2023 post announcement of financial results for the third quarter & nine months ended December 31, 2022",
            "news_id": "6c2f0ab1-16f2-4673-9f72-a8c1f1cd0dd8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ad61ffc-6ea4-45f4-a276-6de71864fdda.pdf",
            "news_date": "2023-02-10 18:32:43",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are enclosing herewith the Investor Presentation on third quarter & nine months ended financial results as on December 31, 2022 and other business matters.",
            "news_id": "401ec448-c4cd-4f3d-8105-5b0445472db2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4a4526e-6f42-4790-a3ab-405ea93005d4.pdf",
            "news_date": "2023-02-04 14:12:14",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For Third Quarter And Nine Months Ended December 31, 2022",
            "news_body": "We would like to inform that the Board of Directors at its meeting held on February 4, 2023 inter alia, considered and approved the Unaudited Standalone and consolidated Financial Results for the third quarter and nine months ended December 31, 2022 as recommended by the Audit Committee.",
            "news_id": "e49b596d-2e28-4c8e-b4cb-5b0e33475093",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=259b16e2-e6c4-4836-b749-5aa1653942c6.pdf",
            "news_date": "2023-02-04 13:54:40",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (LODR) Regulations, 2015.",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, enclosed is the  disclosure of Related Party Transactions on consolidated basis for the half year ended September 30, 2022.",
            "news_id": "cfcf638a-adf4-4041-8d41-a381d602e8b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6aa16b9b-c97d-476c-85c1-f6d2d41cd25a.pdf",
            "news_date": "2022-11-16 17:11:28",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings conference call held on November 05, 2022 post announcement of financial results for the second quarter & half year ended September 30, 2022",
            "news_id": "883d9a5f-381f-4427-86a2-4154558a933a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4cee9ab-53b4-4329-a64b-e3197deb6cb6.pdf",
            "news_date": "2022-11-12 18:29:49",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Investor Presentation on second quarter & half year ended financial results as on September 30, 2022 and other business matters.",
            "news_id": "e6473dcb-9005-4c0e-95a6-414ad824f356",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2aa72cec-d195-461a-9c36-bc59251d20c5.pdf",
            "news_date": "2022-11-05 14:40:00",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30, 2022",
            "news_body": "The Board of Directors at its meeting held on November 5, 2022 inter alia, considered and approved the Unaudited Standalone and consolidated Financial Results  for the second quarter and half year ended September 30, 2022 as recommended by the Audit Committee.",
            "news_id": "1f64f754-fcfc-497a-939d-7a6b14b2ae09",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2e4f97d-3c6f-4465-8245-01c72099b1e4.pdf",
            "news_date": "2022-11-05 13:34:46",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings conference call held on August 10, 2022 post announcement of financial results for the quarter ended June 30, 2022.",
            "news_id": "9050e90a-6a18-461a-b570-e302e577cbdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4c6d0dc-fc43-4c4a-acab-bab9f25b0214.pdf",
            "news_date": "2022-08-17 15:12:18",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Revised Investor presentation on Q1 FY 23 results and other  business matters.",
            "news_id": "2c7c60c1-c329-485e-9b53-dbb6dfc89061",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=052ac7bf-9d59-46ca-9aa9-ddb955cdaf9a.pdf",
            "news_date": "2022-08-10 15:17:39",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Investor Presentation on first quarter ended June 30, 2022 results and business matters.",
            "news_id": "a16c8a4c-df02-4564-8d3f-6468fc9f3e0d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d27d16a-1243-4973-96b6-488f82075a49.pdf",
            "news_date": "2022-08-10 13:10:53",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "We would like to inform that the Board of Directors at its meeting held on August 10, 2022 inter alia, considered and approved the Unaudited Standalone and consolidated Financial Results for the first quarter ended June 30, 2022 as recommended by the Audit Committee as attached.",
            "news_id": "15df7809-29b5-4c63-b45f-eb9e98f06a3e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c59d867-a9e6-4c2c-a8b3-e04f43d17e78.pdf",
            "news_date": "2022-08-10 12:45:02",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions for the half year ended March 31, 2022.",
            "news_id": "1fd1ee10-b745-4755-bc5b-033d795d572b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52d71996-4a1a-44da-be81-2f9d09deab23.pdf",
            "news_date": "2022-05-31 11:49:28",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings conference call held on May 17, 2022 post announcement of financial results for the quarter and year ended March 31, 2022.",
            "news_id": "cffa663e-e8a9-42b4-ba47-547d0ac1d87e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47b0200f-9a69-42f3-ae42-deb30b3e5561.pdf",
            "news_date": "2022-05-24 16:48:13",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Investor Presentation on fourth quarter and year ended results FY22 and business matters.",
            "news_id": "43f84f12-22e6-4329-9372-c20d47222612",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=747b2aee-57cb-4b7c-b05a-45bb0eb233b4.pdf",
            "news_date": "2022-05-16 17:08:18",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31, 2022",
            "news_body": "We would like to inform that the Board of Directors at its meeting held on May 16, 2022 inter alia, considered and approved the Audited Standalone and consolidated Financial Results for the fourth quarter and year ended March 31, 2022 as recommended by the Audit Committee.",
            "news_id": "4d98c76a-53bb-4f6e-a331-ee40f1a5abbd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55dd1c64-16a5-42a1-85f6-8fcb2bfcb143.pdf",
            "news_date": "2022-05-16 14:58:39",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings conference call held on February 8, 2022 post announcement of financial results for the quarter and nine months ended December 31, 2021.",
            "news_id": "d64e2631-65a9-494a-9395-26dbf9ef594d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ec5ef21-a97e-4738-ad39-ded0288246e8.pdf",
            "news_date": "2022-02-14 15:15:03",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Investor Presentation for February, 2022.",
            "news_id": "7d3cfb9d-e9dd-4e53-9d5e-e90841db6f32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89f56f06-d215-4de4-8bcd-ebb81c8c73a2.pdf",
            "news_date": "2022-02-08 11:21:35",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For Quarter And Nine Months Ended December 31, 2021",
            "news_body": "We would like to inform that the Board of Directors at its meeting held on February 07, 2022 inter alia, considered and approved the Unaudited Standalone and consolidated Financial Results for the third quarter and nine months ended December 31, 2021 as recommended by the Audit Committee",
            "news_id": "ecb00da6-e90d-409d-a7dd-fb42a0dd07ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f29d1db-7e87-4140-9ff2-47d634633c49.pdf",
            "news_date": "2022-02-07 17:15:42",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings conference call held on October 25, 2021 post announcement of financial results for the quarter and half year ended September 30, 2021.",
            "news_id": "242725e6-76e6-4f8d-8790-d84d7a7d1671",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9638af22-cfa3-4334-88bd-0df0bef3cb98.pdf",
            "news_date": "2021-10-30 10:18:46",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing  herewith the Investor Presentation for October 2021.<BR>",
            "news_id": "c259464c-ac78-43b3-9983-85ccf5b13709",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ed0197f-845f-4416-a716-258214c6a283.pdf",
            "news_date": "2021-10-25 18:56:53",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ACUTAAS",
            "disp": "Acutaas Chemicals",
            "bse_code": 543349,
            "isin": "INE00FF01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we enclose the following:<BR> 1. Statement showing the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended September 30, 2021.<BR> 2. Standalone & Consolidated  Statements of Assets and Liabilities as on 30th September, 2021.<BR> 3. Standalone and Consolidated Cash Flow Statement for the half year ended 30th September, 2021.<BR> 4. Limited Review Report on standalone and consolidated financial statements issued by the Statutory Auditors of the Company.<BR>",
            "news_id": "f468d8f8-2714-4533-8ad9-c0833f84afac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcdf3395-07ef-4a92-a243-026827bd6d58.pdf",
            "news_date": "2021-10-23 17:28:02",
            "seo": "acutaas-chemicals-ltd",
            "ltp": 2033.5,
            "ch": -16.5,
            "pch": -0.8048780487804879,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 5578,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}